EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa

Piero Olliaro, Juvenal Nkeramahame, Olawale Salami, Catrin E Moore, Philip Horgan, Rita Baiden, Vida Kukula, Alexander Adjei, James Kapisi, Heidi Hopkins, David Kaawa-Mafigiri, Deborah Ekusai-Sebatta und 8 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Piero Olliaro und 19 weiteren Autor:innen. Beteiligte Einrichtung: International Severe Acute Respiratory and Emerging Infection Consortium, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Universal Health Insurance. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Agency for Development and Cooperation, Federal Ministry of Economic Cooperation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We introduce the Antimicrobial Resistance Diagnostic Use Accelerator program, and the articles in this Supplement, which cover the program in 3 sub-Saharan Africa countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsUniversal Health InsuranceHumansDrug Resistance, BacterialAfrica South of the SaharaHealth Services Accessibility

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • International Severe Acute Respiratory and Emerging Infection Consortium, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom.
  • FIND, Geneva, Switzerland.
  • Nuffield Department of Medicine, Big Data Institute, University of Oxford, Oxford, United Kingdom.
  • Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, St George's University of London, London, United Kingdom.
  • Evidence & Impact Oxford, Oxford, United Kingdom.
  • INDEPTH-Network, Accra, Ghana.

Förderung

  • Swiss Agency for Development and Cooperation
  • Federal Ministry of Economic Cooperation

Zitieren

APA

Olliaro, P., Nkeramahame, J., Salami, O., Moore, C. E., Horgan, P., Baiden, R., Kukula, V., Adjei, A., Kapisi, J., Hopkins, H., Kaawa-Mafigiri, D., Ekusai-Sebatta, D., Rutebemberwa, E., Kitutu, F. E., Tinto, H., Kiemde, F., Compaoré, A., Valia, D., Dittrich, S., & ADIP study group (2023). Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad326

Vancouver

Olliaro P, Nkeramahame J, Salami O, Moore CE, Horgan P, Baiden R, et al. Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad326

BibTeX
@article{Olliaro2023,
  author = {Olliaro, Piero and Nkeramahame, Juvenal and Salami, Olawale and Moore, Catrin E and Horgan, Philip and Baiden, Rita and Kukula, Vida and Adjei, Alexander and Kapisi, James and Hopkins, Heidi and Kaawa-Mafigiri, David and Ekusai-Sebatta, Deborah and Rutebemberwa, Elizeus and Kitutu, Freddy Eric and Tinto, Halidou and Kiemde, François and Compaoré, Adélaïde and Valia, Daniel and Dittrich, Sabine and ADIP study group, ADIP study group},
  title = {Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad326}
}
Kostenlos starten →